Does CLOTIAZEPAM Cause Hepatic cytolysis? 16 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Hepatic cytolysis have been filed in association with CLOTIAZEPAM. This represents 5.0% of all adverse event reports for CLOTIAZEPAM.
16
Reports of Hepatic cytolysis with CLOTIAZEPAM
5.0%
of all CLOTIAZEPAM reports
16
Deaths
6
Hospitalizations
How Dangerous Is Hepatic cytolysis From CLOTIAZEPAM?
Of the 16 reports, 16 (100.0%) resulted in death, 6 (37.5%) required hospitalization, and 6 (37.5%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOTIAZEPAM. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does CLOTIAZEPAM Cause?
Coma (65)
Toxicity to various agents (54)
Somnolence (52)
Suicide attempt (31)
Fall (25)
Poisoning (24)
Confusional state (21)
Dizziness (19)
Hypotension (19)
Drug use disorder (17)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which CLOTIAZEPAM Alternatives Have Lower Hepatic cytolysis Risk?
CLOTIAZEPAM vs CLOTRIMAZOLE
CLOTIAZEPAM vs CLOXACILLIN
CLOTIAZEPAM vs CLOXAZOLAM
CLOTIAZEPAM vs CLOZAPINE
CLOTIAZEPAM vs CLOZARIL